Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial

Michael Ezekowitz, Charles V. Pollack, Jonathan L. Halperin, Richard England, Sandra Nguyen, Judith Spahr, Maria Sudworth, Nilo Cater, Andrei Breazna, Jonas Oldgren, Paulus Kirchhof

Research output: Contribution to journal › Article › peer-review

82 Citations (Scopus)
97 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences